share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Chaguturu Sreekanth K

SEC announcement ·  Apr 3 17:06
Summary by Moomoo AI
On April 1, 2024, CVS Health EVP and Chief Medical Officer, Chaguturu Sreekanth K, completed a series of transactions involving the company's common stock. Initially, Chaguturu acquired 6,913 shares of restricted common stock at a price of $79.56 per share. Subsequently, he disposed of 2,298 shares at the same price, which were used to cover the exercise price or tax liability associated with the securities. After these transactions, Chaguturu Sreekanth K's direct holdings in CVS Health totaled 23,666 shares. The total market value of the disposed shares amounted to $182,828.88.
On April 1, 2024, CVS Health EVP and Chief Medical Officer, Chaguturu Sreekanth K, completed a series of transactions involving the company's common stock. Initially, Chaguturu acquired 6,913 shares of restricted common stock at a price of $79.56 per share. Subsequently, he disposed of 2,298 shares at the same price, which were used to cover the exercise price or tax liability associated with the securities. After these transactions, Chaguturu Sreekanth K's direct holdings in CVS Health totaled 23,666 shares. The total market value of the disposed shares amounted to $182,828.88.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more